Showing results (241-250 of 384) with videos related to

Sort By:
Pageof 39
Blood|May 1, 1995
Nonrandom inactivation of the X chromosome in early lineage hematopoietic cells in carriers of Wiskott-Aldrich syndromeG Wengler, J B Gorlin, J M Williamson, et al.
Alimentary Pharmacology & Therapeutics|January 7, 2011
A 13-nation population survey of upper gastrointestinal symptoms: prevalence of symptoms and socioeconomic factorsS Haag, J M Andrews, J Gapasin, et al.
The Journal of Antimicrobial Chemotherapy|November 1, 1990
In-vitro activity of sparfloxacin, a new quinolone antimicrobial agentM A Cooper, J M Andrews, J P Ashby, et al.
The Journal of Antimicrobial Chemotherapy|August 1, 1990
In-vitro comparison of the post-antibiotic effect of vancomycin and teicoplaninM A Cooper, Y F Jin, J P Ashby, et al.
The Journal of Antimicrobial Chemotherapy|December 31, 1997
Concentrations of levofloxacin (HR 355) in the respiratory tract following a single oral dose in patients undergoing fibre-optic bronchoscopyJ M Andrews, D Honeybourne, G Jevons, et al.
The Journal of Antimicrobial Chemotherapy|January 1, 1997
The in-vitro activity of faropenem, a novel oral penemJ M Woodcock, J M Andrews, N P Brenwald, et al.
Revista Da Associacao Medica Brasileira (1992)|May 1, 1995
[Complications of allogeneic microsurgical transplantation of a limb (composite tissue), in rats]L M Ferreira, J P Anthony, S Mathes, et al.
The Journal of Antimicrobial Chemotherapy|June 5, 2001
Lung concentrations of telithromycin after oral dosingO A Khair, J M Andrews, D Honeybourne, et al.
The Journal of Antimicrobial Chemotherapy|December 5, 2000
The in vitro activity of ABT773, a new ketolide antimicrobial agentJ M Andrews, T M Weller, J P Ashby, et al.
Internal Medicine Journal|August 5, 2010
Potentially avoidable surgery in inflammatory bowel disease: what proportion of patients come to resection without optimal preoperative therapy? A guidelines-based auditJ Gapasin, D R Van Langenberg, G Holtmann, et al.
Pageof 39